SCHOTT Pharma Aktie

26,56 EUR +0,94 EUR +3,67 %

21:45:08

STU

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

JETZT LOSLEGEN

Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handeln Smartphone

Marktkap.3,99 Mrd. EUR

KGV31,38Div. Rendite0,47%

WKNA3ENQ5

ISINDE000A3ENQ51

SymbolSTTPF

SCHOTT Pharma Aktien News

Sortieren:Datum Meistgelesen

11.11.24EQS GroupEQS-AFR: SCHOTT Pharma AG & Co. KGaA: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

11.11.24EQS GroupEQS-AFR: SCHOTT Pharma AG & Co. KGaA: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements

27.09.24EQS GroupEQS-PVR: SCHOTT Pharma AG & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

WerbungSCHOTT Pharma-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero

26.09.24EQS GroupEQS-News: SCHOTT Pharma, Gerresheimer, and Stevanato Group announce strategic industry “Alliance for RTU”

05.09.24EQS GroupEQS-News: Promotion for SCHOTT Pharma: Listed on the MDAX for the first time

03.09.24EQS GroupEQS-PVR: SCHOTT Pharma AG & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

29.08.24EQS GroupEQS-News: SCHOTT Pharma delivers strong third quarter results and raises FY 2024 revenue guidance

08.08.24EQS GroupEQS-News: SCHOTT Pharma reinforces commitment to align its climate actions to the requirements of the Paris Agreement

05.08.24EQS GroupEQS-PVR: SCHOTT Pharma AG & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

31.07.24EQS GroupEQS-News: Transforming operational efficiency and sustainability: SCHOTT Pharma introduces nest design with more cavities for prefillable polymer syringes

16.07.24EQS GroupEQS-News: Driving subcutaneous self-injection of large volume doses: SCHOTT Pharma launches large format ready-to-use cartridges for on-body devices

04.07.24EQS GroupEQS-PVR: SCHOTT Pharma AG & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

27.06.24EQS GroupEQS-News: SCHOTT Pharma continues growth path in the second quarter of fiscal year 2024

24.06.24EQS GroupEQS-PVR: SCHOTT Pharma AG & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

17.06.24EQS GroupEQS-PVR: SCHOTT Pharma AG & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

14.06.24EQS GroupEQS-News: Expanding prefillable glass syringe output: SCHOTT Pharma opens state-of-the-art production facility in Lukácsháza, Hungary

23.05.24EQS GroupEQS-PVR: SCHOTT Pharma AG & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

17.05.24EQS GroupEQS-PVR: SCHOTT Pharma AG & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

14.05.24EQS GroupEQS-News: SCHOTT Pharma confirms outlook for FY 24 based on Q2 results; FY 25 impacted by slower growth from syringes

14.05.24EQS GroupEQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma see FY 25 impacted by slower growth from syringes

30.04.24EQS GroupEQS-News: SCHOTT Pharma appoints Tobias Erfurth as Head of Investor Relations

18.03.24EQS GroupEQS-News: SCHOTT Pharma to Expand in the U.S. with New Prefillable Syringe Manufacturing Facility

14.03.24EQS GroupEQS-News: Successful 2024 Annual General Meeting of SCHOTT Pharma: Shareholders approve all items on the agenda

04.03.24EQS GroupEQS-DD: SCHOTT Pharma AG & Co. KGaA: Dr. Jens Schulte, sell

29.02.24EQS GroupEQS-News: SCHOTT Pharma reports good start into fiscal year 2024

26.02.24EQS GroupEQS-AFR: SCHOTT Pharma AG & Co. KGaA: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements

26.01.24EQS GroupEQS-News: SCHOTT Pharma delivers on 2023 targets and continues profitable growth trajectory

15.01.24EQS GroupEQS-AFR: SCHOTT Pharma AG & Co. KGaA: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

19.12.23EQS GroupEQS-News: SCHOTT Pharma delivers right after IPO with strong profitable growth for the full year, at the upper end of its guidance

06.12.23EQS GroupEQS-News: Hello SDAX! SCHOTT Pharma reaches next milestone as a publicly listed company

06.10.23EQS GroupEQS-News: SCHOTT Pharma IPO: Early termination of stabilization period and full exercise of the Greenshoe Option

06.10.23EQS GroupEQS-News: Bank of America Securities Europe SA: Exercise of the Greenshoe Option and Post-stabilisation Period Announcement

05.10.23EQS GroupEQS-DD: SCHOTT Pharma AG & Co. KGaA: Ann-Kristin Erkens, buy

05.10.23EQS GroupEQS-DD: SCHOTT Pharma AG & Co. KGaA: Andreas Reisse, buy

05.10.23EQS GroupEQS-DD: SCHOTT Pharma AG & Co. KGaA: Dr. Almuth Steinkühler, buy

05.10.23EQS GroupEQS-DD: SCHOTT Pharma AG & Co. KGaA: Dr. Jens Schulte, buy

05.10.23EQS GroupEQS-DD: SCHOTT Pharma AG & Co. KGaA: Dr. Wolfgang Wienand, buy

SCHOTT Pharma News

SCHOTT Pharma News: auf dieser Seite finden Sie alle SCHOTT Pharma News und Nachrichten zur SCHOTT Pharma Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch SCHOTT Pharma News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um SCHOTT Pharma News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.